Dysregulated ET-1, ETAR, and ETBR signaling have been observed in murine models of SLE, and pharmacological inhibition with endothelin receptor antagonists (ERAs) has proven beneficial18,19. This evidence concerns the gene EDNRB and systemic lupus erythematosus.